Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer.
about
Gastric cancer: The times they are a-changin'High expression of HEF1 is associated with poor prognosis in urinary bladder carcinoma.Identification of annexin II as a novel secretory biomarker for breast cancer.The Annexin a2 Promotes Development in Arthritis through Neovascularization by Amplification Hedgehog PathwayWhat gastric cancer proteomic studies show about gastric carcinogenesis?Nomogram Incorporating CD44v6 and Clinicopathological Factors to Predict Lymph Node Metastasis for Early Gastric CancerAnnexin A2: its molecular regulation and cellular expression in cancer development.S100 protein family in human cancer.Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients.Annexin A2 plays a critical role in epithelial ovarian cancer.Expression and significance of annexin A2 in patients with gastric adenocarcinoma and the association with E-cadherin.Evaluation of miRNA-196a2 and apoptosis-related target genes: ANXA1, DFFA and PDCD4 expression in gastrointestinal cancer patients: A pilot study.CEACAM6 is a prognostic biomarker and potential therapeutic target for gastric carcinoma.Identification and Comparison of Differentiation-Related Proteins in Hepatocellular Carcinoma Tissues by Proteomics.Calcium channel α2δ1 subunit as a novel biomarker for diagnosis of hepatocellular carcinoma.Identification of natural compounds targeting Annexin A2 with an anti-cancer effect.
P2860
Q26776195-593C9F84-3815-478D-A829-0478BDDE6E46Q33968807-F05947B0-8696-404D-91D6-8ADA49F8D4AAQ34982525-F1A519C0-CB39-4EC2-94B5-D3002D94FDACQ35952353-52104559-4E9C-4FF7-B1B6-8768623F1887Q36002404-D714FDCC-1382-44C8-8157-08993D24920DQ36092350-C39FA48A-A0C7-45CC-8308-BA8B13E32BEFQ37586765-3DF52315-7752-4D00-BB20-0CDD550AB3E9Q37650123-45A15C71-6477-4A58-B884-F0B91E6ACE44Q37723978-B607C082-AC1A-4D2D-9C12-E8ADAA9B38D8Q41641709-1B55EAC1-A4A9-47A3-9DAD-086DB30B7853Q42096061-6C762F77-A18D-4732-8C56-A6E7424A22CBQ46179491-BE9AF6C9-574A-4009-8743-A0F1B94F3CE7Q46303343-8BDFA29E-59D8-4080-921B-E3E0855ED9DCQ49166081-CB6ED620-8F69-4488-80B0-715859E26AF1Q52652985-4A9FA007-09C3-48D5-BEF4-E21D4C25B2A3Q52672650-0B9C0AFF-CE92-4C61-B3F2-66F5FB001B6E
P2860
Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Upregulated expression of anne ...... patients with gastric cancer.
@ast
Upregulated expression of anne ...... patients with gastric cancer.
@en
type
label
Upregulated expression of anne ...... patients with gastric cancer.
@ast
Upregulated expression of anne ...... patients with gastric cancer.
@en
prefLabel
Upregulated expression of anne ...... patients with gastric cancer.
@ast
Upregulated expression of anne ...... patients with gastric cancer.
@en
P2093
P2860
P356
P1476
Upregulated expression of anne ...... patients with gastric cancer.
@en
P2093
Huiju Wang
Qiong Yang
Zaiyuan Ye
Zhongsheng Zhao
P2860
P2888
P356
10.1186/1477-7819-10-103
P577
2012-06-08T00:00:00Z
P5875
P6179
1008350424